Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.53 | N/A | -63.08% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.53 | N/A | -63.08% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about current market conditions impacting performance. They are prioritizing cost management and operational improvements.
Management acknowledged the ongoing challenges in the market.
They emphasized a focus on improving operational efficiency moving forward.
Teladoc Health's disappointing EPS results indicate ongoing struggles within the company. The stock fell by 1.91% following the announcement, reflecting investor concerns about profitability and market conditions. Without revenue figures or guidance, uncertainty remains about the company's future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
REVVITY INC
Apr 28, 2025